Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia

Completed · Phase 2

Conditions studied: Waldenstrom Macroglobulinemia

In brief

The purpose of this research is to study how helpful thalidomide is in controlling the disease and to study any side effects from taking thalidomide.

Key facts

Study ID
NCT00083707
Run by
University of Arkansas
People needed
40
Starts
1999-01-01
Expected to finish
2003-02-01
Last updated by the study team
2010-07-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.